Compare Angelalign Technology, Inc. with Similar Stocks
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-17.51%
0%
-17.51%
6 Months
11.45%
0%
11.45%
1 Year
38.77%
0%
38.77%
2 Years
31.89%
0%
31.89%
3 Years
8.69%
0%
8.69%
4 Years
-46.67%
0%
-46.67%
5 Years
-82.21%
0%
-82.21%
Angelalign Technology, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
23.37%
EBIT Growth (5y)
-10.79%
EBIT to Interest (avg)
44.90
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.91
Sales to Capital Employed (avg)
0.43
Tax Ratio
16.51%
Dividend Payout Ratio
36.59%
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
15.01%
ROE (avg)
4.56%
Valuation key factors
Factor
Value
P/E Ratio
55
Industry P/E
Price to Book Value
2.92
EV to EBIT
44.27
EV to EBITDA
24.73
EV to Capital Employed
13.29
EV to Sales
2.79
PEG Ratio
0.13
Dividend Yield
NA
ROCE (Latest)
30.02%
ROE (Latest)
5.28%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot : Jun 2024
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.01%)
Strategic Entities with highest holding
Highest Public shareholder
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
2,886.70
2,097.30
37.64%
Operating Profit (PBDIT) excl Other Income
325.50
87.40
272.43%
Interest
13.60
12.00
13.33%
Exceptional Items
0.00
0.00
Consolidate Net Profit
205.20
78.20
162.40%
Operating Profit Margin (Excl OI)
63.00%
-16.60%
7.96%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 37.64% vs 28.60% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 162.40% vs 45.35% in Dec 2024
About Angelalign Technology, Inc. 
Angelalign Technology, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






